Skip to content

Clinical trials

Phase 3 Lung Neoplasms trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 3 Country / region: Chile Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20091
20151
20201
20211
20231
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Amgen2
Gustave Roussy, Cancer Campus, Grand Paris2
Boehringer Ingelheim1
Bristol-Myers Squibb1
Genmab1
International Atomic Energy Agency1
Merck KGaA, Darmstadt, Germany1
Nuvalent Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms16
Carcinoma, Non-Small-Cell Lung11
Carcinoma3
Lung Diseases2
Neoplasms2
Adenocarcinoma of Lung1
Anemia1
Pleural Effusion1
Pleural Effusion, Malignant1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.